Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis
about
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral AmyloidosisKinetics of serum amyloid protein A in casein-induced murine amyloidosis.Effects of amyloid induction on plasma protein turnover, and its implicationConformational flexibility of the serum amyloid precursor SAAInhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.The effect of human chorionic gonadotropin and placental lactogen on lymphocyte transformation in vitro.An update of clinical, pathologic, and biochemical aspects of amyloidosis.Degradation of amyloid A and serum amyloid A by red blood cell haemolysate in patients with familial mediterranean fever.Heterogeneity of murine regulatory T cells. I. Subpopulations of amplifier and suppressor T cells.The in-vitro influence of serum amyloid A isoforms on enzymes that regulate the balance between esterified and un-esterified cholesterol.Isolation and structural properties of murine SAA--the acute phase serum precursor of amyloid AA.First evidence for the existence of multiple isoforms of bovine serum amyloid-A (apoSAA).Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: A hypothesis
P2860
Q35639988-4135F2E8-4041-4181-AF85-25E1C6BAF020Q35905772-D6753162-C8BB-4629-A457-14990DB39E76Q36077591-FC7BE741-EF09-408F-9E47-3D9201FBD338Q36090757-E79EE10B-ADA1-4962-B3E6-9A7765B35594Q36337215-0CC08017-3CA8-4DC2-91AE-1BBA9272FABEQ36359933-8969C421-1AAC-4B87-98CC-BCDE7566A1EBQ37050824-FCFB8356-EDD5-4165-9537-F7D72773EA58Q39790332-8611CEB0-092B-408E-8CA9-2FA34EA9394CQ40320186-2493D373-173F-484C-B48B-3917E1D7E528Q40824123-D584AC08-B45E-4E58-92AA-92CAAD757712Q42941019-A1D69C9F-594F-475A-AFDA-680DACBDB9FFQ43776630-6184E7B3-4891-487A-AE71-C0AE793E6F3CQ44417562-AAAB3780-C952-406F-8E5C-A59EE0083460Q46731775-947EB1AF-D4B9-4C5C-8088-3C13E7ED9D47Q58165773-83839BCA-FA77-4989-BB2D-DBE1C2444319
P2860
Suppression of in vitro antibody response by a serum factor (SAA) in experimentally induced amyloidosis
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Suppression of in vitro antibo ...... rimentally induced amyloidosis
@ast
Suppression of in vitro antibo ...... rimentally induced amyloidosis
@en
type
label
Suppression of in vitro antibo ...... rimentally induced amyloidosis
@ast
Suppression of in vitro antibo ...... rimentally induced amyloidosis
@en
prefLabel
Suppression of in vitro antibo ...... rimentally induced amyloidosis
@ast
Suppression of in vitro antibo ...... rimentally induced amyloidosis
@en
P2093
P2860
P356
P1476
Suppression of in vitro antibo ...... rimentally induced amyloidosis
@en
P2093
Aldo-Benson MA
Shirahama T
P2860
P304
P356
10.1084/JEM.142.1.236
P407
P577
1975-07-01T00:00:00Z